OPG has been implicated as a potential mediator and biomarker in a variety of cardiovascular diseases, particularly cardiometabolic conditions (Pérez de Ciriza et al., 2015) and pulmonary hypertension (Lawrie et al., 2008, Condliffe et al., 2012). The gene discussed is TNFRSF11B; the disease is cardiovascular disorder.